Reduced tocopherol content of B cells from patients with chronic lymphocytic leukemia

Area of Science:

• Biochemistry
• Hematology
• Oncology

Background:

• Tocopherol (Vitamin E) plays a crucial role in cellular antioxidant defense.
• Alterations in tocopherol levels have been implicated in various disease states, including cancers.
• Leukemias, such as chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL), are characterized by malignant lymphocytes.

Purpose of the Study:

• To investigate tocopherol content in lymphocytes, erythrocytes, and plasma of patients with CLL and HCL.
• To compare tocopherol levels in leukemia patients with those of healthy individuals.
• To determine if tocopherol distribution differs between T-cell and B-cell subgroups in CLL.

Main Methods:

• Quantification of tocopherol using a sensitive high-performance liquid chromatography (HPLC) method.
• Analysis of tocopherol in lymphocytes, erythrocytes, and plasma.
• Subfractionation of lymphocytes into T-cell and B-cell populations for CLL patients.

Main Results:

• Lymphocytes from CLL patients exhibited significantly lower tocopherol content (1.7 ± 1.0 µg/10⁹ cells) compared to normal subjects (3.8 ± 0.7 µg/10⁹ cells).
• Mononuclear cells from HCL patients showed elevated tocopherol levels (6.2 ± 1.0 µg/10⁹ cells).
• In CLL, T-cell tocopherol levels were comparable to normals, but B-cell tocopherol content was markedly reduced (2.6 ± 1.0 µg/10⁹ cells vs. 6.0 ± 1.3 µg/10⁹ cells).

Conclusions:

• Tocopherol metabolism is significantly altered in chronic lymphocytic leukemia and hairy cell leukemia.
• The reduction in tocopherol is specifically localized to the B-cell population in CLL.
• These findings suggest a potential role for tocopherol dysregulation in the pathogenesis or progression of these leukemias.